Suppliers / Pacira Pharmaceuticals

Pacira Pharmaceuticals

United States Updated 9 July 2026

Pacira Pharmaceuticals is a finished-dose manufacturer based in United States. It appears in 3 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by MHRA (UK). Its most recent recorded inspection, by US FDA, closed on 19 April 2023 as VAI.

0
active US DMFs
0
valid CEPs
3
registered plants 1 with an FDA FEI number
3
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
8 of 8 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 19 April 2023 VAI US FDA
  • 1 March 2018 VAI US FDA
  • 22 July 2015 VAI US FDA
  • 10 February 2014 VAI US FDA
  • 27 March 2013 VAI US FDA
  • 23 February 2012 VAI US FDA
  • 17 June 2011 VAI US FDA
  • 24 January 2011 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
SAN DIEGO, United States Not on file
SAN DIEGO, United States Not on file
San Diego, United States 3002783962

Filings and GMP by regulator

Regulator Filings GMP certificates
US FDA 3 None
MHRA (UK) None 2

Questions about Pacira Pharmaceuticals

Does Pacira Pharmaceuticals hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Pacira Pharmaceuticals. It does have 3 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
Is Pacira Pharmaceuticals FDA-registered?
One site operated by Pacira Pharmaceuticals carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Pacira Pharmaceuticals's last inspection go?
The most recent inspection on record closed on 19 April 2023 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 8 inspections are on file.
Where does Pacira Pharmaceuticals manufacture?
3 registered sites are on record, in United States (SAN Diego and San Diego among others). Every site is listed on this page with the register it came from.
Which regulators recognise Pacira Pharmaceuticals's GMP?
Current GMP certificates are on record from MHRA (UK). GMP recognition covers the manufacturing site, separately from any filing on the substance itself.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Pacira Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 19 April 2023.

Comparable suppliers

Aaa Pharmaceuticals also in United States Aarkish Pharmaceuticals NJ also in United States Abbott Laboratories also in United States Abon Pharmaceuticals also in United States Access Business Group also in United States

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates